Results 101 to 110 of about 51,442 (242)

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma [PDF]

, 2007
Janos Geli, Nimrod Kiss, Fredrik Lanner, Theodoros Foukakis, Natalia Natalishvili, Olle Larsson, Per Kogner, Anders Höög, Geoffrey Clark, Tomas J. Ekström, Martin Bäckdahl, Filip Farnebo, Catharina Larsson   +12 more
openalex   +1 more source

Laparoscopic resection of pheochromocytoma (paraganglioma) of the organ of Zuckerkandl in a pediatric patient

, 2021
Katherine Kramme, Robin Fountain, Michael J. Leinwand   +2 more
openalex   +1 more source

Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell‐Induced Ferroptosis in Ovarian Cancer

Advanced Science, Volume 12, Issue 46, December 11, 2025.
An integrative analysis combining in vitro genome‐wide immune screens, in vivo ICB screens, and clinical data mining identifies METTL5 as a key tumor‐intrinsic immune factor. Mechanistic studies further reveal the importance of the METTL5‐ATF4‐SLC7A11/SLC3A2‐ferroptosis axis in modulating antitumor immune responses. These findings highlight METTL5 as a
Jiakai Hou, Cheng‐Wei Ju, Nicholas A. Egan, Yanjun Wei, Yunfei Wang, Minghao Dang, Tianyi Zhou, Leilei Shi, Ningbo Zheng, Si Chen, Ashley M. Guerrero, Xiaofang Liang, Wanfu Wu, Areej Akhtar, Chitra Dhiman, Debanwita Roy Burman, Andro E. Gerges, Mason D. Flores, Han Li, Li‐Sheng Zhang, Marleen Kok, Xiaobo Mao, Linghua Wang, Qin Feng, Yiwen Chen, Sanghoon Lee, Daniel J. McGrail, Nidhi Sahni, Chuan He, Amir A. Jazaeri, Weiyi Peng   +30 more
wiley   +1 more source

Pheochromocytoma

AJN, American Journal of Nursing, 2009
Brown, M, Grossman, AB, Bornstein, SR
openaire   +5 more sources

Genetic analysis of pheochromocytoma and paraganglioma complicating cyanotic congenital heart disease

, 2022
Tatsuki Ogasawara, Yoichi Fujii, Nobuyuki Kakiuchi, Yusuke Shiozawa, R. Sakamoto, Yoshihiro Ogawa, Katsuki Ootani, Etsuro Ito, Tomoaki Tanaka, Kenichiro Watanabe, Yusaku Yoshida, Noriko Kimura, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Seishi Ogawa   +16 more
openalex   +2 more sources

Preoperative Amlodipine Is More Efficacious Than Prazosin in Preventing Intraoperative Haemodynamic Instability in Pheochromocytoma/Paraganglioma Patients: Interim Analysis of a Pilot Randomized Controlled Study [PDF]

, 2021
Saba Samad Memon, Sanjeet Kumar Jaiswal, Robin Garg, Rohit Barnabas, Manjunath Goroshi, Anurag Lila, Vijaya Sarathi, Abhay Dalvi, Mahadeo Garale, Indrani Hemantkumar, Rajendra Patel, Shrikanta Oak, Virendra Patil, Nalini S. Shah, Tushar Bandgar   +14 more
openalex   +1 more source

Clinically Inspired Multimodal Treatment Using Induced Neural Stem Cells‐Derived Exosomes Promotes Recovery of Traumatic Brain Injury through Microglial Modulation

Advanced Science, Volume 12, Issue 46, December 11, 2025.
This study explores the therapeutic potential of iNSC‐Exo via local and systemic delivery in TBI mice. It is found that iNSC‐Exo enhances NRXN signaling through Microglia_Nrg3 and Microglia_Rarb, effectively promoting functional and neurological recovery, suggesting a new therapeutic strategy for TBI. Abstract Traumatic brain injury (TBI) poses serious
Jiaojiao Li, Maoxiang Xu, Boyu Cai, Xiangyu Li, Zhanping Liang, Xiaohuan Xia, Haitao Zhang, Zhiwen Zhang, Fei Tan, Jialin Charlie Zheng   +9 more
wiley   +1 more source

Supplementary Table 4 from Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis

, 2023
Joakim Crona, Samuel Backman, Rajani Maharjan, Markus Mayrhofer, Peter Stålberg, Anders Isaksson, Per Hellman, Peyman Björklund   +7 more
openalex   +1 more source

Pheochromocytoma associated with a succinate dehydrogenase subunit B mutation: A minireview and a case report [PDF]

, 2023
Emad Rezkallah, Andrew Elsaify, Victorino Martin, Laura Viva, Sath Nag, Barnabas Green, Matthew Cheesman, Wael Elsaify   +7 more
openalex   +1 more source

Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia‐inducible factor‐2α inhibitor, in healthy participants

British Journal of Clinical Pharmacology, Volume 91, Issue 12, Page 3366-3377, December 2025.
Aims Casdatifan is an orally bioavailable small‐molecule hypoxia‐inducible factor‐2α (HIF‐2α) inhibitor currently in development for treating patients with clear cell renal cell carcinomas. The aim of this study was to characterize the pharmacokinetics (PK), pharmacodynamics and safety of casdatifan in healthy participants.
Mohammad Ghasemi, Ji Yun Kim, Lisa Seitz, Lixia Jin, Paul G. Foster, Kai H. Liao, Tzuling Cheng, Elaine Paterson, Maria Velinova, Nicole Rivera Rosario, Reza Khosravan, Balaji Agoram   +11 more
wiley   +1 more source